Unique biorepository stores samples from Alberta COVID-19 patients for future research
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
Study identified potential approach to treat severe respiratory distress in patients with COVID-19
On Jun. 5, 2020, early data from a clinical study suggested that blocking the Bruton tyrosine kinase (BTK)…
Calquence showed promising clinical improvement in majority of 19 hospitalised COVID-19 patients
On Jun. 5, 2020, results were published in Science Immunology showed that Calquence (acalabrutinib), a Brutonﾒs tyrosine kinase…
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
ViralClear added St. David’s HealthCare to phase II trial for broad-spectrum oral anti-viral COVID-19 candidate
On Jun. 5, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma, announced it had expanded its patient enrollment…
Novavax awarded Department of Defense contract for COVID-19 vaccine
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Measles | Polio | Vaccine
World leaders made historic commitments to provide equal access to vaccines for all
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
COVID-19 | Diagnostics | NIH
HHS announced new laboratory data reporting guidance for COVID-19 testing
On Jun. 4, 2020, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specified…
iBio announced second COVID-19 vaccine program
On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….
The Gates Foundation pledged $16 billion to Gavi, the Vaccine Alliance, to protect the next generation with vaccines
On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…
Virginia Tech researchers established a reverse genetics system to facilitate COVID-19 research
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
Roche initiated initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On Jun. 4, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccine
On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…
Introduction and spread of SARS-CoV-2 in the greater Boston area
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
NIH reported early results show benefit of remdesivir for COVID-19
On Jun. 2, 2020, the NIH reported that early results showed that remdesivir benefited hospitalized patients with severe…
FDA cleared IND for iNKT Cells to treat COVID-19 patients
On Jun. 2, 2020, Agenus announced the FDA’s clearance of AgenTus’ IND application for an allogeneic iNKT therapy….
The USDA announced the first confirmed case of a dog in the US to test positive for SARS-CoV-2
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
Albert Einstein College of Medicine awarded $1 million for COVID-19 research from the Price Family Foundation
On Jun. 2, 2020, Albert Einstein College of Medicine announced it had received a $1 million challenge grant…
Trevena announced collaboration with Imperial College London to evaluate TRV027 in COVID-19 patients
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
Altimmune launched clinical trial of T-COVIDTM, an investigational intranasal immune modulator for treatment of patients with early COVID-19
On Jun. 1, 2020, Altimmune announced the FDA had authorized the Company to proceed with a clinical trial…
LabCorp launched new COVID-19 clinical trial site to connect patients with US research trials
On Jun. 1, 2020, LabCorpﾮ announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
FDA authorized OPKO Health clinical trial evaluating RAYALDEE in COVID-19 patients
On Jun. 1, 2020, OPKO Health announced the FDA had authorized OPKO to undertake a Phase 2 trial…
Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
PathGroup announced new COVID-19 testing option
On Jun. 1, 2020, PathGroup announced the availability of a new, minimally-invasive nasal swab collection option as a…
Resverlogix announced COVID-19 clinical trial program launch
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneﾒs…
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
The US Dept of Defense launched effort to collect COVID-19 convalescent plasma
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
Gilead announced results from phase 3 trial of Remdesivir in patients with moderate COVID-19
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…